Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2025-12-25 @ 1:35 AM
NCT ID:
NCT01761994
Eligibility Criteria:
Inclusion Criteria:
* patients who have at least one of the hemorrhagic tendencies of following conditions and needs CRRT hemodynamically;
1. Platelet count \< 100,000
2. aPTT \> 60 sec
3. PT-INR \> 2.0
4. active hemorrhage
5. surgery within 48 hours
6. cerebral hemorrhage within 3 months or history of major bleeding
7. septic shock or DIC.
Exclusion Criteria:
* pregnancy, breast feeding, possibility of pregnancy,
* allergy to nafamostat mesilate,
* other conditions that physician consider unfit for candidate.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01761994
Study Brief:
Protocol Section:
NCT01761994